Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

ALZN Company Profile and Key Details

NASDAQ : ALZN

Alzamend Neuro

$2.50
-0.1-3.85%
Open: 1:41 PM
60.7
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Alzamend Neuro, Inc. (ALZN) stock declined over -3.85%, trading at $2.50 on NASDAQ, down from the previous close of $2.60. The stock opened at $2.60, fluctuating between $2.40 and $2.60 in the recent session.

Stock Snapshot

2.6
Prev. Close
7.24M
Market Cap
2.4
Day Low
-0.02
P/E Ratio
-101.88
EPS (TTM)
-1.31
Cash Flow per Share
2.6
Open
2.9M
Number of Shares
2.6
Day High
97.35%
Free Float in %
-0.59
Book Value
172.94K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 29, 20252.742.742.582.60162.13K
Jul 28, 20252.842.892.622.77425.17K
Jul 25, 20252.983.012.922.96204.27K
Jul 24, 20253.003.042.942.99111.96K
Jul 23, 20253.123.142.923.01345.4K
Jul 22, 20253.223.273.153.20131.61K
Jul 21, 20253.273.353.253.2662.31K
Jul 18, 20253.413.493.243.28200.24K
Jul 17, 20253.533.593.343.42245.46K
Jul 16, 20253.233.603.163.53478.38K
Jul 15, 20253.123.303.103.17258.85K
Jul 14, 20253.213.283.093.16347.71K
Jul 11, 20253.003.352.953.20433.15K
Jul 10, 20253.023.133.003.05167.37K
Jul 09, 20252.903.092.893.06174.72K
Jul 08, 20252.872.962.852.9586.4K
Jul 07, 20252.902.932.812.88123.38K
Jul 03, 20253.033.042.902.9489.38K
Jul 02, 20252.893.052.873.00365.94K
Jul 01, 20252.902.922.812.92106.41K

Contact Details

Atlanta, GA 30326

United States

https://www.alzamend.com844 722 6333

About Company

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Company Information

Employees4
Beta-0.28
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsApril
SectorHealthcare
IndustryBiotechnology

Stock Peers

ARGX
3.6+0.60%
argenx SE$598.79REGN
-0.485-0.09%
Regeneron Pharmaceuticals, Inc.$558.15VRTX
7.585+1.65%
Vertex Pharmaceuticals Incorporated$468.41ALNY
5.76+1.77%
Alnylam Pharmaceuticals, Inc.$330.55KRTX
0.09+0.03%
Karuna Therapeutics, Inc.$329.83UTHR
-0.58-0.19%
United Therapeutics Corporation$297.56MDGL
0.24+0.08%
Madrigal Pharmaceuticals, Inc.$294.40SGEN
-0.16-0.07%
Seagen Inc.$228.74BGNE
0.9+0.49%
BeiGene, Ltd.$184.71RETA
0.04+0.02%
Reata Pharmaceuticals, Inc.$172.36

Frequently Asked Questions

What is the current Alzamend Neuro, Inc. (ALZN) stock price?
Alzamend Neuro, Inc. (NASDAQ: ALZN) stock price is $2.50 in the last trading session. During the trading session, ALZN stock reached the peak price of $2.60 while $2.40 was the lowest point it dropped to. The percentage change in ALZN stock occurred in the recent session was -3.85% while the dollar amount for the price change in ALZN stock was -$0.10.
ALZN's industry and sector of operation?
The NASDAQ listed ALZN is part of Biotechnology industry that operates in the broader Healthcare sector. Alzamend Neuro, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ALZN?
Mr. Kenneth S. Cragun CPA
Chief Financial Officer
Mr. Henry C. W. Nisser Esq.
Pres, Gen. Counsel & Director
Mr. Stephan Jackman
Chief Executive Officer & Director
Mr. Kenneth S. Cragun C.P.A.
Chief Financial Officer
How ALZN did perform over past 52-week?
ALZN's closing price is 0.78% higher than its 52-week low of $2.40 where as its distance from 52-week high of $135.54 is -98.08%.
How many employees does ALZN have?
Number of ALZN employees currently stands at 4.
Link for ALZN official website?
Official Website of ALZN is: https://www.alzamend.com
How do I contact ALZN?
ALZN could be contacted at phone 844 722 6333 and can also be accessed through its website. ALZN operates from 3500 Lenox Road NE, Atlanta, GA 30326, United States.
How many shares of ALZN are traded daily?
ALZN stock volume for the day was 172.94K shares. The average number of ALZN shares traded daily for last 3 months was 1.71M.
What is the market cap of ALZN currently?
The market value of ALZN currently stands at $7.24M with its latest stock price at $2.50 and 2.9M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph